"As we look forward to next year, we just see so much need for primary vaccine, we are hearing it all over the world, and also boosters," M...

The European Union has set a target of vaccinating 70% of its adult population by the end of the summer, but has struggled to secure the do...

The distribution of Moderna's vaccine to more than 3,700 locations in the United States will vastly widen the rollout started last week by ...

The Food and Drug Administration on Friday approved an emergency use authorization for Moderna's vaccine, the second COVID-19 vaccine to re...

Wall Street analysts and investors widely expected Tesla to join the S&P 500 after the company posted its fourth consecutive profitable qua...

The vaccines for the deadly Covid-19 are in various stages of trial. ET takes a look at four vaccine candidates, where the results of the c...

Scientists and drug companies across the world are accelerating various treatments and vaccine options to tackle Covid-19, which has claime...

An IIM- Ahmedabad alumna, Nayar founded Nykaa in 2012 after quitting as MD of Kotak Mahindra Capital Company, where she had spent 18 years.